共 50 条
- [11] Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficienciesCLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 210 (02): : 91 - 103Kobayashi, Roger H.Litzman, JiriMelamed, IsaacMandujano, J. FernandoKobayashi, Ai LanRitchie, BruceGeng, BobAtkinson, T. PrescottRehman, SyedHoeller, SonjaTurpel-Kantor, EvaKreuwel, HuubSpeer, J. C.Gupta, Sudhir
- [12] Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary ImmunodeficienciesFRONTIERS IN IMMUNOLOGY, 2019, 10Kobayashi, Roger H.Gupta, SudhirMelamed, IsaacMandujano, J. FernandoKobayashi, Ai LanRitchie, BruceGeng, BobAtkinson, Thomas PrescottRehman, SyedTurpel-Kantor, EvaLitzman, Jiri
- [13] Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiencyACTA PAEDIATRICA, 2007, 96 (10) : 1474 - 1478Fasth, AndersNystrom, Jeanette
- [14] Efficacy, Tolerability and Safety of Cutaquig®, a New Subcutaneous Human Immunglobulin 16.5% in Adult Patients with Primary ImmunodeficienciesJOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S64 - S65Latysheva, E.Rodina, Y.Sizyakina, L.Totolian, A.Tuzankina, I
- [15] Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continentsIMMUNOTHERAPY, 2019, 11 (12) : 1057 - 1065Suez, DanielKrivan, GergelyJolles, StephenStein, MarkGupta, SudhirParis, Kennethvan Hagen, P. MartinBrodszki, NicholasEngl, WernerLeibl, HeinzMcCoy, BarbaraYel, Leman
- [16] Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency DiseasesJournal of Clinical Immunology, 2014, 34 : 204 - 211Hirokazu KaneganeKohsuke ImaiMasafumi YamadaHidetoshi TakadaTadashi ArigaMartin BexonMikhail RojavinWilson HuMidori KobayashiJohn-Philip LawoShigeaki NonoyamaToshiro HaraToshio Miyawaki
- [17] Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency DiseasesJOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (02) : 204 - 211Kanegane, HirokazuImai, KohsukeYamada, MasafumiTakada, HidetoshiAriga, TadashiBexon, MartinRojavin, MikhailHu, WilsonKobayashi, MidoriLawo, John-PhilipNonoyama, ShigeakiHara, ToshiroMiyawaki, Toshio
- [18] SAFETY/TOLERABILITY OF HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASESANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S97 - S97Paris, K.Derfalvi, B.Hussain, I.Haddad, E.Dicso, F.Darter, A.Doralt, J.Engl, W.Mccoy, B.Yel, L.
- [19] Safety and Efficacy of Home-Based Subcutaneous Immunoglobulin G in Elderly Patients with Primary Immunodeficiency DiseasesPOSTGRADUATE MEDICINE, 2011, 123 (05) : 186 - 193Stein, Mark R.Koterba, AlanRodden, LindaBerger, Melvin
- [20] Erratum to: Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency DiseasesJournal of Clinical Immunology, 2014, 34 : 520 - 520Hirokazu KaneganeKohsuke ImaiMasafumi YamadaHidetoshi TakadaTadashi ArigaMartin BexonMikhail RojavinWilson HuMidori KobayashiJohn-Philip LawoShigeaki NonoyamaToshiro HaraToshio Miyawaki